Schedule 13D ownership disclosure

Arcus Biosciences Inc

Security class unavailable · CUSIP: 03969F109

Event date: 2024-10-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
4.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-24-280681
Form type
SC 13D/A
Filer
Arcus Biosciences, Inc.
CIK
CIK 1724521
Filed
Dec 17, 2024
Reporting period
Oct 28, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub